News Column

Sanofi - Annual General Shareholder Meeting of May 5, 2014

May 7, 2014



ENP Newswire - 07 May 2014

Release date- 06052014 - Paris, France - Sanofi (EURONEXT: SAN and NYSE: SNY) announced its Annual General Shareholder Meeting was held today at the Palais des Congres in Paris.

All resolutions were adopted by its shareholders.

During the meeting, shareholders approved, among other resolutions, the individual Company and consolidated financial statements for the year 2013. At the General Meeting, shareholders decided the distribution of a cash dividend in the amount of EUR2.80 per share which will be detached on Euronext Paris on May 12, 2014 with payment as of May 15, 2014.

The General Meeting also elected Patrick Kron as Director and renewed as Directors Christopher Viehbacher, Robert Castaigne and Christian Mulliez, for a term of four years, i.e., until the General Meeting called to approve the financial statements for the year 2017. Lord Douro, whose term of office has expired, did not express the desire to have his mandate renewed.

After the General Meeting, the new Board of Directors is comprised of 16 members, of whom four are women and eleven are independent Directors. It consists of the following members:

Serge Weinberg, Chairman of the Board of Directors

Christopher Viehbacher, Chief Executive Officer

Laurent Attal

Uwe Bicker

Robert Castaigne

Thierry Desmarest

Jean-Rene Fourtou

Claudie Haignere

Patrick Kron

Igor Landau

Fabienne Lecorvaisier

Suet-Fern Lee

Christian Mulliez

Carole Piwnica

Klaus Pohle

Gerard Van Kemmel

The voting results will be available on the Company's website (www.sanofi.com) in the coming days.

The audiocast of the Annual General Shareholder Meeting is available on the Company's website (www.sanofi.com).

About Sanofi

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Media Contact:

Gregory Miley

Tel: + (33) 1 53 77 46 46

Investor Contact:

Sebastien Martel

Tel: + (33) 1 53 77 45 45


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: ENP Newswire


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters